Triple-amiRNA VEGFRs inhibition in pancreatic cancer improves the efficacy of chemotherapy through EMT regulation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Triple-amiRNA VEGFRs inhibition in pancreatic cancer improves the efficacy of chemotherapy through EMT regulation

Published:2017-01 Issue: Volume:245 Page:1-14
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Huang Jianfei,Mei Haijun,Tang Zhiyuan,Li Jieying,Zhang Xiaojing,Lu Yixiang,Huang Fang,Jin Qin,Wang Zhiwei

Funder

Six Talent Peaks Project fund

Technological Innovation and Demonstration of Social Undertakings Project fund

Translational Medicine Research fund

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference43 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015

2. Targeted therapies for pancreatic adenocarcinoma: where do we stand, how far can we go?;Grapsa;World J. Gastrointest. Oncol.,2015

3. The updated incidences and mortalities of major cancers in China, 2011;Chen;Chin. J. Cancer,2015

4. Current status and progress of pancreatic cancer in China;Lin;World J. Gastroenterol.,2015

5. Smarter drugs emerging in pancreatic cancer therapy;Kleger;Ann. Oncol.,2014

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vascular endothelial growth factor-C and its receptor-3 signaling in tumorigenesis;3 Biotech;2023-09-01

2. An amino acid metabolism-based seventeen-gene signature correlates with the clinical outcome and immune features in pancreatic cancer;Frontiers in Genetics;2023-06-02

3. Liposomes targeting the cancer cell-exposed receptor, claudin-4, for pancreatic cancer chemotherapy;Biomaterials Research;2023-05-26

4. Artificial miRNAs as therapeutic tools: Challenges and opportunities;WIREs RNA;2021-01

5. Recent Advances in Multi-target Drugs Targeting Protein Kinases and Histone Deacetylases in Cancer Therapy;Current Medicinal Chemistry;2020-12-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3